Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MS4 Research Institute (MS4RI) is a non-profit clinical research organization based in Albuquerque, New Mexico, dedicated to advancing the treatment of Multiple Sclerosis (MS). The institute specializes in conducting Phase I through Phase IV clinical trials, collaborating with major pharmaceutical companies to evaluate novel disease-modifying therapies. Led by Dr. Corey Ford, a recognized expert in neuroimmunology, MS4RI provides patients with access to emerging treatments such as monoclonal antibodies and sphingosine-1-phosphate receptor modulators. Beyond clinical trials, the institute focuses on patient education and the development of standardized metrics for assessing MS progression. MS4RI serves as a vital link between academic research and the commercial development of neurological therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MS4 Research Institute.